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In Brief Teixeira et al. report that neurotransmitter release from hippocampal serotonin terminals modulates CA3-to-CA1 excitatory transmission and spatial memory formation. 5-HT4 receptors are centrally involved in relaying both modulatory consequences, supporting the rationale to target this receptor subtype for pharmacotherapy of cognitive impairment.
INTRODUCTION
Learning and memory models suggest that modulation by subcortical inputs may stabilize Hebbian homosynaptic plasticity to permit long-lasting changes in synaptic strength and that these dynamic changes are the substrates for learning and memory (Bailey et al., 2000; Hunt et al., 2013) . Monoaminespredominantly serotonin (5-HT), dopamine, and norepinephrine-constitute the main class of subcortical modulatory input to higher brain regions involved in learning and memory. Recent studies demonstrate that local release of dopamine in the hippocampus plays a critical role in hippocampal-dependent learning and memory (Kempadoo et al., 2016; Rosen et al., 2015; Takeuchi et al., 2016) . Although 5-HT is the prototypical modulatory neurotransmitter regulating sensitization and associative learning in the marine snail Aplysia (Bailey et al., 2000) , relatively little is known about the role of 5-HT in memory formation in mammals.
Interestingly, the hippocampus, a mammalian brain region essential for declarative memory formation (Milner et al., 1998) , receives dense serotonergic input from the raphe nuclei, which send fibers to the interface of the stratum radiatum (SR) and the stratum lacunosum-moleculare (SLM) layers in the CA1 area (Ihara et al., 1988) . This site of innervation may enable 5-HT release to modulate both the direct entorhinal cortex input to CA1 via the perforant path (PP), and the indirect inputs that arrive in CA1 via the Schaffer collaterals (SC) from CA3. Both pathways undergo long-term potentiation (LTP) in response to tetanic stimulation, a form of plasticity thought to be important for memory formation (Basu and Siegelbaum, 2015; Gruart et al., 2006; Pastalkova et al., 2006; Tsien et al., 1996; Whitlock et al., 2006) and both pathways are necessary for optimal memory formation (Brun et al., 2002; Nakashiba et al., 2008; Suh et al., 2011) .
However, there is conflicting evidence as to the role of 5-HT in hippocampal memory formation. Although bath-applied 5-HT agonists and inhibitors of 5-HT reuptake (SSRIs) can alter hippocampal plasticity (Cai et al., 2013; Cooke et al., 2014; Rubio et al., 2013) , most studies report inhibitory effects of 5-HT on long-term potentiation or excitatory transmission (Corradetti et al., 1992; Jahnsen, 1980; Ropert, 1988; Staubli and Otaky, 1994) . A positive role of 5-HT in memory is implied by the findings that cognitive deficits associated with depression or after tryptophan depletion are associated with reduced 5-HT levels (Cowen and Sherwood, 2013; Mendelsohn et al., 2009 ). However, systemically applied drugs that increase 5-HT signaling largely impair memory consolidation (Almeida et al., 2010; Gray and Hughes, 2015) . Finally, 5-HT receptor subtype-specific compounds and mouse knockouts implicate the 5-HT1A, 5-HT3, and 5-HT4 receptors in regulating memory formation (Meneses, 2013; Ogren et al., 2008) . While these studies demonstrate principal modulatory aspects of 5-HT on hippocampal function and learning and memory, there has been no direct examination of the effects of evoked 5-HT release from the serotonergic inputs to the hippocampus. Here we investigate the consequences of optogenetic alteration of 5-HT release from genetically defined serotonergic neurons on the physiological properties of CA1 pyramidal neurons, and on cognitive performance in a hippocampus-dependent spatial memory test.
RESULTS
Light-Induced Regulation of Serotonergic Neuronal Activity Using ePet1-cre;Ai32 Mice We first established a mouse line that expresses a channelrhodopsin2-enhanced green fluorescent fusion protein (ChR2-eYFP) exclusively in serotonergic neurons. To this end, we combined the RC::LSL-CHR2 allele, which consists of conditional floxed ChR2-eYFP targeted to the ROSA26 locus and will here be abbreviated as ''Ai32'' (Madisen et al., 2012) , with the transgenic B6. Cg-Tg(Fev-cre) 1Esd/J allele, which expresses Cre-recombinase under the pet1 promoter and will here be abbreviated as ''ePet1-cre'' (Scott et al., 2005) . ePet1-cre;Ai32 mice display YFP immunoreactivity (YFP+) in 5-HT immuno- positive (5-HT+) neurons in the brainstem ( Figure 1A) , with high specificity (99.5% ± 0.2% 5-HT+/YFP+) and high transgene efficacy (95.3% ± 1.1% YFP+/5-HT+; Figures 1B and 1C) . Serotonergic fibers labeled with YFP immunoreactivity were observed throughout the hippocampal region, with the highest local density found at the border of SLM and SR ( Figure 1D ).
Photostimulation (10-ms-long pulses of 473 nm light) at a frequency of 2 or 20 Hz increased the firing frequency of raphe serotonergic neurons in acute coronal brain slices of ChR2-expressing ePet1-cre Evoked Terminal Release of 5-HT in CA1 Potentiates CA3 to CA1 Inputs To study the effect of photostimulated release of 5-HT on hippocampal function, we next performed whole-cell recordings from CA1 pyramidal cells in acute horizontal brain slices, with inhibition intact ( Figure 3A ). Consistent with a previous report (Varga et al., 2009 ), we found a small, transient hyperpolarization of CA1 pyramidal neurons of 0.63 ± 0.11 mV in response to photostimulation at 2 Hz (t (13) = 5.617; p < 0.001), which increased to a 1.12 ± 0.19 mV hyperpolarization (t (13) = 6.054; p < 0.001) upon photostimulation at 20 Hz ( Figure 3B ). This hyperpolarization was abolished by a cocktail of 5-HT receptor 1A, 3, and 4 antagonists (2 Hz ACSF versus 5-HT receptor block: t (16) = 2.534; p = 0.0221; Figure 3B ). Next, we investigated whether 5-HT release altered synaptic excitation of the CA1 pyramidal neurons by either their SC or PP inputs ( Figures 4A and 4D ). We electrically stimulated the SR of CA1 at 0.05 Hz to evoke an SC-mediated fast postsynaptic potential (PSP) in CA1 pyramidal neurons (PNs). After 5 min of baseline recording, we delivered 50 light pulses at 2 Hz. Optogenetic activation of serotonergic terminals increased the amplitude of the SC-evoked PSP in CA1 PNs by 96% ± 26% (oneway RM ANOVA: F (2.49, 17.42) = 5.35, p = 0.0114; Figures 4B and 4C ; extended holding see Figure S2B ). Photostimulation had no effect on the SC-evoked PSP in ePet1-cre À/À ;Ai32 4E and 4F) . Together these data demonstrate serotonergic potentiation of the CA3 to CA1 (SC) but not EC to CA1 (PP) inputs upon optogenetic stimulation of serotonergic axons in CA1.
The enhancement in the SC-evoked PSP could reflect an increase in the excitatory postsynaptic current (EPSC), a decrease in feedforward inhibition, or an increase in dendritic integration of the EPSC. To distinguish among these possibilities, we examined the effect of optogenetic 5-HT release on the extracellular field EPSP, whose amplitude is proportional to the local EPSC. We electrically stimulated the SR of CA1 at 0.05 Hz to evoke an SC-mediated, fast, excitatory postsynaptic field potential (fEPSP) in CA1 ( Figure 4G ). After 5 min of baseline recording, we delivered 50 light pulses at 20 Hz. Optogenetic activation of serotonergic terminals increased the amplitude of the SCevoked fEPSP in CA1 PNs by 117% ± 40% (one-way RM ANOVA: F (1.229, 6.143) = 4.883, p = 0.064; Figures 4H and 4I) , similar to the effect on the intracellular PSP. Direct evidence that the potentiation does not reflect a decrease in inhibition is provided by experiments using GABA antagonists presented below (see Figures 7 and S8B) .
Next, we investigated whether serotonergic fEPSP potentiation occurs in vivo ( Figure 4J ). We targeted optical stimulation to the cell bodies of serotonergic neurons, because acute penetration of the CA1 PN layer with the optical fiber disrupts LFP responses to electrical stimulation of SC (data not shown). We positioned the optical fiber in the MR, where we find the serotonergic neurons reside that project to CA1 (Figures S7A-S7C ). We electrically stimulated SCs at 0.2 Hz to evoke fast, excitatory postsynaptic field potentials (fEPSPs) in dorsal CA1 of anesthetized mice. On its own, this protocol did not elicit potentiation or depression of fEPSP responses (one-way RM ANOVA: F (1.686, 30.34) = 2.287, p = 0.1261; Figures S2E-S2G) (Huang et al., 2004) . To test for an effect of neurotransmitter release from serotonergic neurons on fEPSPs in vivo, we delivered 50 light pulses at 20 Hz after 5 min of baseline recording. Optogenetic activation of serotonergic neurons increased the amplitude of the SCevoked fEPSP in CA1 PNs by 40% ± 9% (one-way RM ANOVA: F (1.409, 43.68) = 14.03, p = 0.0001; Figures 4K and 4L) . . Posthoc genotype effect in 3 min light on block is indicated; **p < 0.01, ***p < 0.001.
Optogenetic Stimulation of Serotonergic Axons in CA1 Increases Spatial Memory Formation
Next, we studied the consequences of optogenetically stimulating serotonergic neurons on spatial memory using the Morris water maze test (MWM) (Figures S3A and S3F) . We hypothesized that 5-HT release may enhance spatial memory storage given the potentiation of CA3-CA1 synaptic excitation observed both in acute hippocampal slices as well as in anesthetized mice. Hence, we first subjected mice to a weak training protocol ( Figures S3B and S3G ). ChR2-expressing mice and their littermate controls with optical fiber implants in the DR or MR were trained in the MWM for 5 days using 3 trials per day, with continuous photostimulation during training (473 nm, 20 Hz, 10 ms, 10 mW). Mice improved their performance during training, measured as a decreased latency to find the platform (DR: F (4,104) = 32.044; p < 0.0001; MR: F (4,128) = 29.981; p < 0.0001; Figures S3C and S3H). Spatial memory was assessed in a probe trial in which the platform was removed without photostimulation. We did not detect an effect of genotype or implant location on probe trial performance ( Figures S3D, S3E , S3I, and S3J).
We hypothesized that the hyperlocomotion phenotype observed with raphe stimulation ( Figures 2D and 2H ) might interfere with attention-related aspects important for memory formation and might be elicited by neurotransmitter release in non-hippocampal serotonergic projection fields. Hence, we next used a protocol to selectively activate serotonergic input into the hippocampus, and specifically to the dorsal CA1, by implanting optical fibers targeting the SLM/SR border ( Figure 5A ; Figure S4A ). Optogenetic stimulation of serotonergic fibers in dorsal CA1 had no effect on locomotor activity (OF distance : Genotype 3 Stimulation interaction: F (11, 341) = 1.10; p = 0.3607; Figure 5B ). In the MWM, both groups of mice equally improved their performance during training (Training day effect: F (4,72) = 11.32; p < 0.0001; Figure 5G ). However, in the probe trial that tests memory retrieval ChR2-expressing mice spent significantly more time in the target zone of the pool (where the platform was located) than their littermate controls or the average of the three non-target zones (Search zone 3 Genotype interaction: F (1, 18) = 8.033; p = 0.0110; Figure 5H ). Furthermore, ChR2 mice showed significantly more platform crossings than their littermate controls (t (18) = 2.054; p = 0.0274; Figure 5I ), suggesting that serotonergic terminal stimulation in dorsal CA1 improved cognition.
In contrast to memory retrieval, we did not detect a Genotype 3 Stimulation effect on behavior in the OF or Hence performance in the MWM was not confounded by alterations in ambulatory activity, anxiety-like behavior, or swimming behavior. Also, the improvement in memory was specific to spatial learning, as ChR2-mediated stimulation did not affect performance in a social memory recognition task (Treatment 3 Mouse Novelty effect: F (3, 60) = 1.03; p = 0.3874; Mouse novelty effect: F (1, 60) = 47.81; p < 0.0001; Figure 5E ), which is dependent on the CA2 region (Hitti and Siegelbaum, 2014) .
To control for unspecific effects of genotype or off target activation, we performed several additional control experiments. First we confirmed that ChR2 expression in serotonergic neurons without light stimulation did not affect behavior in any test we performed ( Figures S5C-S5J ). Second, we investigated whether light traveling through the targeted CA1 region might reach the dentate gyrus (DG) to excite local serotonergic axon terminals of this upstream hippocampal subfield to produce observed behavioral effects. To address this possibility, we selectively activated serotonergic input into the dorsal DG by implanting optical fibers targeting its outer blade ( Figure S4C ). Optogenetic stimulation of serotonergic fibers in the dorsal DG had ) hippocampal slices induces a rapid hyperpolarization of CA1 pyramidal neurons. A cocktail of 5-HT receptor antagonists (GR113808, 100 nM; Odansetron, 10 nM; WAY100,635, 100 nM) blocked this hyperpolarization. Vm traces are taken from experiments representative of the population average. t test-based significant differences from baseline and between groups are indicated. *p < 0.05, ***p < 0.001. (A-C) When electrical stimulation of SR of CA1 at 0.05 Hz was paired with 50 blue light pulses (2 Hz), the PSP of CA1 pyramidal neurons increased. A cocktail of 5-HT receptor antagonists (GR113808, 100 nM; Odansetron, 10 nM; WAY100,635, 100 nM) blocked this potentiation of the CA3-CA1 synapse. (D-F) When the same protocol was applied to the perforant path, we observed no potentiation. 2 Hz and 20 Hz experiments were averaged together because no effect of blue light stimulation frequency and no interaction between blue light stimulation frequency and time was detected. (G-I) When electrical stimulation of SR of CA1 at 0.05 Hz was paired with 50 blue light pulses (20 Hz), and local field potentials were recorded extracellularly (EC), the fEPSP in CA1 was increased.
(legend continued on next page) no effect on MWM behavior ( Figure S6 ). Both groups of mice equally improved their performance during training (Training day effect: F (4,96) = 12.329; p < 0.0001; Figure S6C ). Likewise, in the probe trial, no Search Zone by Genotype interaction was detected (F (1,24) = 1.296; p = 0.2662; Figure S6D ). Furthermore, ChR2 mice did not differ significantly from littermate controls for platform crossings (F (1,24) = 0.882; p = 0.357; Figure S6E ), demonstrating that serotonergic terminal stimulation in the dorsal DG does not impact spatial memory formation in the MWM. One potential concern with in vivo stimulation of serotonergic axons in dorsal CA1 is that it is expected to trigger antidromic action potentials, which could travel back to the raphe and excite collaterals that release 5-HT in other brain regions. We therefore directly assessed whether local optogenetic stimulation of serotonergic axons in hippocampus is able to excite serotonergic neurons in the raphe. As raphe neuron activation has been found to induce immediate early gene c-Fos expression (Ahmari et al., 2013; Teissier et al., 2015; Veerakumar et al., 2014) , we examined Fos staining in the raphe following optical stimulation in dorsal CA1 ( Figure S7 ). To maximize our sensitivity of detecting activation, we first mapped the raphe region that contains serotonergic neurons projecting to the dorsal CA1 region. To that end, we injected a retrograde Cre-dependent CAV2 virus conditionally expressing ZsGreen into dorsal CA1. We detected retrogradely labeled serotonergic neurons exclusively in MR ( Figure S7C ) and hence restricted our analysis to this raphe sub-region. We failed to detect an effect of hippocampal serotonergic photostimulation in enhancing Fos staining in 5-HTergic MR neurons compared to controls (no effect of genotype; t (1,4) = 4.514; p = 0.1008; Figure S7G ). However, direct optical stimulation of MR 5-HTergic neurons enhanced 5-HTergic Fos reactivity compared to controls (t (1,4) = 6.662; Figure S7L ). Together, these data indicate that stimulation of raphe projections in dorsal CA1 did not antidromically activate serotonergic neurons in the raphe. Thus, any behavioral effects of optogenetic activation likely reflect local actions of 5-HT release within CA1. Further support for a local role of 5-HT in hippocampus comes from optogenetic inhibition experiments, discussed next.
Optogenetic Inhibition of Serotonergic Axons in CA1
Reduces Spatial Memory Formation Does endogenous serotonergic activity in CA1 normally contribute to memory formation? To examine this question, we expressed the light-gated proton pump Archaerhodopsin (Arch), which inhibits neural activity upon photostimulation, in serotonergic neurons by crossing ePet1-cre mice to the RC::LSL-Arch line, which consists of conditional floxed ArcheYFP targeted to the ROSA26 locus and will here be abbreviated as ''Ai35'' (Madisen et al., 2012) . Arch-expressing mice (ePet1-cre+/À;Ai35+/+) and their littermate control mice (ePet1-creÀ/À; Ai35+/+) were implanted with a fiber optic probe targeting the CA1 SLM/SR border ( Figure 6A ; Figure S4B ). Mice were initially trained in the MWM for 6 days (3 trials a day), with continuous photostimulation during training on days 4-6 (532 nm, 10 mW) ( Figure 6F ). Both groups of mice improved performance as the test progressed (effect of time for D1-D6: F (5, 85) = 10.262; p < 0.001; Figure 6G ). In a subsequent probe trial without light stimulation, both groups of mice showed comparable low levels of performance (Zones 3 Genotype: F (1, 17) = 0.007; p = 0.9343; Zones: F (1, 17) = 4.267; p = 0.0545; Platform crossings: t (17) = 0.4037; p = 0.6915; Figure 6I ). To increase spatial reference memory and avoid a possible floor effect, we trained mice for 3 additional days with light stimulation, which further improved their performance (effect of time for D6-D9: F (3, 51) = 4.946; p = 0.0043; Figure 6G ). In a subsequent second probe trial (P2), we found that the Arch-expressing mice exposed to photostimulation during training now showed a significant impairment in memory during the probe trial compared to control littermates. We detected a trend for Search Zone by Genotype interaction (Zones 3 Genotype: F (1, 17) = 4.170; p = 0.057), with control mice spending more time in the Target zone than in the Other zones, while Arch mice showed no preference ( Figure 6H) . We also detected an interaction of probe trial performance and genotype (F (1, 17) = 4.7; p = 0.0447) as well as a genotype effect for platform crossings on P2 (t (17) = 0.2509; p = 0.0225), with control mice showing 65.4% more platform crossings than Arch mice ( Figure 6I ). These data demonstrate a decrease in cognitive performance when serotonergic cell signaling is inhibited during training. Arch mice did not differ from controls in the OF (OF distance : Genotype 3 Stimulation interaction: F (11, 286) = 1.738; p = 0.0648; OF CenterTime : Genotype 3 Stimulation interaction: F (11, 286) = 0.703; p = 0.7356), FST (Genotype 3 Stimulation: F (11, 308) = 0.376; p = 0.9647), or social memory recognition task 
5-HT Elicited Synaptic Potentiation of CA3-to-CA1 Inputs Is Mediated by 5-HT4 Receptors
To investigate the extent to which the electrophysiological and behavioral effects of 5-HT release may be related, we studied the role of specific 5-HT receptors in these actions. The acute transient hyperpolarization of CA1 pyramidal neurons is blocked by the 5-HT receptor antagonist cocktail ( Figure 3B ) and by 5-HT1AR blockade alone (t (4) = 3.587; p = 0.6527; Figure 7A ). However, the effect is not altered by either a 5-HT4R antagonist (t (9) = 3.587; p = 0.0059) or by blocking GABA A and GABA B receptors (t (7) = 3.674; p = 0.0079) ( Figure 7A ). This result is consistent with findings that photostimulation of the MR to CA1 projections in the rat induces a 5-HT1A receptor-dependent hyperpolarization of CA1 pyramidal cells (Varga et al., 2009 ). Conversely, the potentiation of the SC CA3-CA1 synapse is blocked by the 5-HT receptor antagonist cocktail (Figures 4B and 4C) and by a 5-HT4R antagonist alone (treatment 3 time interaction: two-way RM ANOVA: F (20, 200) = 3.658, p < 0.001, Figure 7B ) but is not affected by 5-HT1AR blockade (+150% ± 45%, baseline versus last 5 min: t (3) = 3.324; p = 0.0449, 5-HT1AR blockade versus ACSF: t (9) = 1.793; p = 0.063, Figure 7C) , or GABA receptor blockade (+185% ± 22%, baseline versus last 5 min: t (9) = 3.881; p = 0.0037, GABA blockade versus ACSF: t (17) = 1.506; p = 0.17, Figure 7C ; Figure S8A ). The 5-HT4R antagonist fully blocked the PSP potentiation upon photostimulation with either a 20 Hz train (one-way RM ANOVA: F (20, 84) = 0.5058, p = 0.9572; Figures 7B and 7C ) or a 2 Hz train (oneway RM ANOVA: F (3.28, 19.69) = 1.372, p = 0.2806, Figure S8B ; Figure 7C ). We next investigated whether the CA3-CA1 potentiation is expressed pre-or postsynaptically. To address this question, we examined the paired-pulse ratio before and after optical stimulation, as a measure of presynaptic function. We did not detect a significant effect of photostimulated 5-HT release in whole-cell (t (16) = 0.9795; p = 0.3419, Figure 7D ) or field (one-way RM ANOVA: F (4.387, 21.93) = 1.555, p = 0.2187, Figure 7E ) recordings, suggesting that the effect is mediated postsynaptically through 5-HT4 receptors on CA1 pyramidal neurons (Peñ as-Cazorla and Vilaró , 2015) . In further support of a postsynaptic mechanism, we find cell-intrinsic changes in patched PNs in response to optogenetic neurotransmitter release from serotonergic axons, with input resistance increasing by $15% (n = 8, p = 0.0201; Figure 7F ).
Bidirectional Modulation of Memory Formation through Systemic Administration of Drugs Targeting 5-HT4 Receptors
To determine the importance of 5-HT4R activation in spatial learning, we examined the effect of systemic administration of the specific antagonist GR125487 (10 mg/kg, i.p.) and agonist BIMU8 (30 mg/kg, i.p.) (Figure 8 ). Injection of GR125487 prior to MWM training impaired probe trial performance, significantly decreasing platform crossings (t (34) = 2.064; p = 0.0467; Figure 8D ), but did not alter Search Zone preference (Zones 3 Genotype: F (1, 34) = 0.485; p = 0.4907; Figure 8C ). Conversely, BIMU8 injections prior to MWM training enhanced probe trial performance. We detected a trend for Search Zone by Genotype interaction (Zones 3 Genotype: F (1, 17) = 3.318; p = 0.0862), with BIM-treated mice spending more time in the Target zone than in the Other zones, while Saline-treated mice showed no preference ( Figure 8G ). BIM-treated mice also significantly increased platform crossings while Saline-treated mice did not (probe trial 3 genotype interaction: F (1, 17) = 9.462; p = 0.0068; Figure 4I ). We also tested the effect of BIMU8 and GR125487 in the OF and FST. BIMU8 treatment significantly reduced ambulatory activity in the OF (F (2, 46) = 12.582; p < 0.0001, Figure 8I ), potentially complicating the interpretation of MWM behavior. However, center activity and FST behavior were not affected by BIMU8 treatment (F (2, 46) = 0.784; p = 0.4626, Figure 8J ; F (2, 23) = 0.173; p = 0.8422, Figure 8K ), suggesting that emotional behavior and swimming abilities do not confound MWM behavior. GR125487 treatment had no effect on OF or FST behavior (Figures 8I-8K ). Together these data suggest that hippocampal 5-HT4R activation is both necessary for optimal memory formation and sufficient to enhance memory formation.
DISCUSSION
Together, our data reveal that the serotonergic input to the hippocampal CA1 region participates in both potentiation of SC CA3-CA1 synaptic excitation and memory storage performance. Moreover, these effects appear to be mediated by the 5-HT4 receptor.
5-HT4 receptors signal through diverse G-protein-dependent and G-protein-independent pathways (Bockaert et al., 1990 (Bockaert et al., , 2011 Dumuis et al., 1988) . Intriguingly, their canonical coupling to Ga s highlights a role of 5-HT in memory formation that potentially mirrors the cAMP-dependent facilitatory action of 5-HT on the sensory-to-motor neuron synapse in Aplysia (Brunelli et al., 1976; Kandel and Schwartz, 1982) , suggesting a functional evolutionary conservation. However, whereas in Aplysia 5-HT acts on presynaptic 5-HT receptors to enhance transmitter release, we find no effect of 5-HT release on the paired-pulse ratio, suggesting that the CA3-CA1 potentiation is expressed postsynaptically.
Our results are consistent with an effect of 5-HT to directly enhance the SC glutamatergic EPSP. Thus, the 5-HT4 receptor-mediated potentiation occurs independently of GABA receptor activation. These data are in line with Htr4 expression by CA1 pyramidal neurons and the lack of Htr4 expression by CA1 GABAergic neurons (Andrade, 1998; Peñ as-Cazorla and Vilaró , 2015; Torres et al., 1996) . Our findings are also congruent with transient pharmacologic 5-HT4 receptor activation producing persistent EPSP spike potentiation (Mlinar et al., 2006) . Indeed, our whole-cell recordings revealed a small but significant increase in input resistance, indicating that cell-intrinsic properties contribute to the potentiation of postsynaptic potentials, although the magnitude of the EPSP and fEPSP potentiation (100%) is too large to be solely accounted for by the change in resistance (15%). Future experiments will be useful in dissecting the relative contribution of alterations in synaptic strength compared to intrinsic excitability.
We also identified a 5-HT1A receptor-mediated fast, transient, GABA-independent hyperpolarization of CA1 pyramidal neurons. This result is consistent with findings that photostimulation of the MR-to-CA1 projections in the rat induces direct 5-HT1A receptor-dependent hyperpolarization of CA1 pyramidal cells (Varga et al., 2009 ). Importantly, we found that the 5-HT4 receptor-mediated effect predominates, lasting for at least 30 min. This balance toward 5-HT4 receptor-mediated synaptic excitation was at first surprising, as we had originally hypothesized to find a dominant 5-HT1A receptor-mediated inhibition, which had been suggested by in vitro work using bath application of serotonergic drugs (Corradetti et al., 1992; Jahnsen, 1980; Ropert, 1988; Staubli and Otaky, 1994) . The contrasting outcome demonstrates the critical role that the spatio-temporal parameters of extracellular 5-HT distribution play in determining cell-physiological consequences and emphasizes importance of optogenetic approaches to examine effects of release of endogenous modulatory transmitters (Rosen et al., 2015) . Our findings are in line with 5-HT1A receptors being located predominantly at extra-synaptic and non-synaptic sites (Riad et al., 2000) , where they participate in 5-HT volume transmission and might serve as inhibitory spill-over detectors. Additional 5-HT receptor genes are expressed in the hippocampus, including Htr2a, Htr2C, and Htr7 (Tanaka et al., 2012) , but their role has not been studied here. Consequently, we do not rule out that these receptors might also relay physiological information with behavioral consequences. Likewise, a partial GABA dependence might be present and detectable with increased N.
We find no effect of photostimulated 5-HT release on synaptic excitation evoked by the direct entorhinal cortical input to CA1 pyramidal neurons. This dissociation suggests that 5-HT release in CA1 can selectively modulate the indirect versus the direct hippocampal pathway. Interestingly, 5-HT potentiates the temporoammonic-CA1 synapse in rat hippocampal slices after pharmacologic 5-HT transporter blockade (Cai et al., 2013) . The discrepancy in outcome again likely relates to the spatio-temporal differences in extracellular 5-HT concentrations elicited by both serotonergic manipulations and points to its possible synapse selective allocation in changing experimental conditions. Our finding that both 2 and 20 Hz optical stimulation of terminal 5-HT release are able to potentiate the SC CA3-CA1 synapse has important implications. Because serotonergic neurons fire at 2-20 Hz in vivo (Cohen et al., 2015; Liu et al., 2014; Wang et al., 2015) , our findings suggest that potentiation of SC CA3-CA1 synapses likely occurs during physiological patterns of (C and D) During probe trial, no effect of treatment was detected for zone times (C), but GR125487-injected mice crossed the platform area significantly fewer times (D). (E and F) Mice were treated with the 5-HT4 receptor agonist BIMU8 or with saline vehicle for 5 days, 20 min before water maze training. (G and H) Probe trial performance was significantly improved in BIMU8-injected mice, which spent more time in the target zone on P2 (G) and crossed the platform location more often (H) than saline injected Controls. (I-K) Mice were treated with GR125487, BIMU8 or Saline 20 min before testing. BIMU8 treatment reduced ambulatory activity in the OF, while GR125487 had no effect (I). No effect of treatment was detected for OF center time (J) or FST floating time (K). *p < 0.05, **p < 0.01, ***p < 0.001. activity where it can contribute to a behavioral enhancement in spatial memory. This interpretation is supported by our control experiment, demonstrating that light spread to the DG does not contribute to the behavioral phenotype. Furthermore, we do not find evidence that terminal stimulation in CA1 activates serotonergic activity throughout the brain, while direct activation of serotonergic neurons at the cell body level in either the DR or the MR does not phenocopy CA1 terminal stimulation. Finally, CA1 terminal inhibition of serotonergic fibers produces the opposite behavioral phenotype, impairing spatial memory, demonstrating that endogenous serotonergic activity normally contributes to memory formation. While 5-HT is generally thought to be not sufficient to tonically activate postsynaptic receptors in vivo under baseline conditions in the hippocampus, our data are congruent with tonic coding properties of serotonergic neurons (Cohen et al., 2015) as well as 5-HT4 receptor antagonists impacting hippocampal physiology (Kemp and Manahan-Vaughan, 2005; Wawra et al., 2014) .
Our pharmacological experiments also support a link between the action of 5-HT on the SC CA3-CA1 synapse and behavior, as we demonstrate bidirectional modulation of memory formation in the Morris water maze task through systemic stimulation or inhibition of 5-HT4 receptor signaling. By choosing a systemic approach, we activate 5-HT4 receptors throughout the organism, and interaction with non-CA1 receptors can complicate the interpretation of the results. For example, we find that 5-HT4 receptor agonism inhibits locomotion in the OF, while terminal manipulation of 5-HTergic activity in CA1 does not impact OF locomotion. Importantly systemic 5-HT4 receptor agonism did not impact swimming behavior, and we did not detect other consequences that would complicate our interpretation of MWM data. As for the locus of the effect on MWM behavior, we can likewise not conclude but only suggest a role of CA1 5-HT4 receptors. Hence our pharmacology experiments allow us to formulate hypotheses regarding necessity and sufficiency of 5-HT4 receptors present on CA1 pyramidal neurons that can be tested for example with conditional genetics. Importantly, our data are also informative in the context of pharmacotherapy.
Behavioral effects are by and large in line with the effects of global 5-HT depletion, which impairs memory performance (Hritcu et al., 2007; Matsukawa et al., 1997) . However, global increases of 5-HT signaling through systemic SSRI treatment impairs Morris water maze performance (Majlessi and Naghdi, 2002 ) and short-term spatial memory in a Y maze (Gray and Hughes, 2015) , indicating a more complex interaction between the effects of multiple 5-HT receptor subtypes. Research on 5-HT4 receptors is congruent with our findings, with 5-HT4 agonists improving olfactory discrimination performance (Restivo et al., 2008) and place/object recognition memory (Lamirault and Simon, 2001 ) and an antagonist impairing associative memory (Marchetti et al., 2000) , as well as inhibiting low-frequency stimulation-induced LTD in CA1 pyramidal neurons (Kemp and Manahan-Vaughan, 2005) . Hence our data not only provide mechanistic insight into how serotonergic signaling pathways are recruited in the spatio-temporal context of circuit-specific terminal neurotransmitter release, but also support the notion that serotonergic drugs targeting the 5-HT4 receptor may provide an effective means for modulating cognitive function.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Further information and requests for reagents may be directed to, and will be fulfilled by, the Lead Contact and corresponding author, Dr. Mark Ansorge (ma2362@cumc.columbia.edu) EXPERIMENTAL MODEL AND SUBJECT DETAILS ePet1-cre (Scott et al., 2005) , Ai32 and Ai35 (Madisen et al., 2012) female and male mice were maintained on a 129SvEv/Tac background at the Rodent Neurobehavioral Analysis Core at Columbia University or the University of Toronto. The ePet1-cre line was originally generated on the (C57BL/6 x SJL)F2 background and has been backcrossed in our lab to 129SvEv/Tac for >10 generations. The Ai lines were generated on the (129S6/SvEvTac x C57BL/6NCrl)F1 and have been backcrossed in our lab to 129SvEv/Tac for 6 generations. Double transgenic and their single transgenic littermate controls were housed in groups (two to five mice per cage) and maintained in a 12 hr light/dark cycle with access to food and water ad libitum. Experiments were conducted blind and in compliance with the Principles of Laboratory Animal Care National Institute of Health (NIH) guidelines and the institutional animal committee guidelines. We used two groups of transgenic mice expressing different opsins (channelrodopsin2 or archaerodopsin) in serotonergic cells. For serotonergic cell activation we used two genotypes: ePet1-cre +/À ;Ai32 +/+ (ChR2) and ePet1-cre ;Ai35 +/+ (Control). Mice were tested at 3 -6 months of age.
METHOD DETAILS Drug Administration
For electrophysiology, the pharmacological agents were applied to the slice preparation by dissolving them in the perfused ACSF. Applied concentrations were: 5-HT4 antagonist, GR113808 (100 nM); 5-HT3 antagonist, odansetron (10 nM); 5-HT1A antagonist, WAY100635 (100 nM). These antagonists were chosen because they target 5-HT receptors that are prominently present in CA1 (see Allen Brain Atlas). The 5-HT receptor antagonist cocktail contained all three antagonists. GABA block was performed with the GABA-A receptor antagonist SR-95531 (2 mM) and the GABA-B receptor antagonist CGP-35348 (1 mM).
For the water maze, the 5-HT4 antagonist GR125487 was dissolved in 0.9% NaCl and administered intraperitoneally at 10 mg/kg 20min before training. The 5-HT4 agonist BIMU8 was dissolved in 0.9% NaCl and administered intraperitoneally at 30 mg/kg 20min before training.
Electrophysiological Recording and Analysis
For all raphe-related experiments, coronal brainstem slices including the dorsal or median raphe nuclei were sliced with a Dosaka Pro 7 Linear Slicer (DSK) in sucrose-substituted ACSF. Electrophysiological recordings were performed in regular ACSF (in mM): 128 NaCl, 10 D-glucose, 26 NaHCO 3 , 2 CaCl 2 , 2 MgSO 4 , 3 KCl, 1.25 NaH 2 PO 4 , pH 7.4 and saturated with 95% O 2 /5% CO 2 at 31 C-33 C. To maintain 5-HT synthesis, 2.5 mM L-tryptophan was included during the recovery period. Patch pipettes contained the following (in mM): 120 potassium gluconate, 5 KCl, 2 MgCl 2 , 4 K 2 -ATP, 0.4 Na 2 -GTP, 10 Na 2 -phosphocreatine, and 10 HEPES buffer (adjusted to pH 7.3 with KOH). Neurons were visualized with a fixed-staged microscope (Olympus BX50WI) and 5-HT neurons were targeted based on the expression of eGFP. Whole-cell recordings were made in current-clamp mode with a Multiclamp 700B amplifier (Molecular Devices). All data were acquired at 20 kHz and low-pass filtered at 3 kHz using pClamp10.2 and Digidata1440 software. Analysis was performed using pClamp 10.2 software (Molecular Devices).
For whole-cell recordings, horizontal brain slices were prepared from the hippocampus of P49-P90 mice. Animals were anesthetized with isoflurane and then perfused intracardially with ice-cold (2 C) sucrose-replaced ACSF (S-ACSF) containing (in mM): NaCl (10), NaH 2 PO 4 (1.2), KCl (2.5), NaHCO 3 (25), glucose (25), CaCl 2 (0.5), MgCl 2 (7), sucrose (190), pyruvate (2), continuously bubbled with 95%/5% O 2 /CO 2 . After decapitation and brain removal, brains were submerged in the S-ACSF and hemisected. The cerebellum and anterior portion of the brain were removed. The hemisected brain was then cut in the horizontal plane at a 10 -12 angle in the ventromedial direction to optimally achieve a transverse section (perpendicular to the longitudinal axis of the hippocampus) and sliced into 400 mm-thick sections on a Leica VT1200s sectioning system. Slices between bregma distance À2.16 to À3.96 were then incubated in a 34 C solution consisting of 50% S-ACSF and 50% recording ACSF containing (in mM): NaCl (125), NaH 2 PO 4 (1.25), KCl (2.5), NaHCO 3 (25), Glucose (25), CaCl 2 (2), MgCl 2 (1), pyruvate (2) for 20 min and then sat at room temperature until recording. When ready for recording, slices were placed into a submerged chamber in the rig at 30 C-32 C, and constantly supplied at 4-5 mL/min with 95%/5% O 2 /CO 2 R-ACSF.
Whole cell current clamp recordings were obtained from pyramidal neurons in CA1 using patch pipettes (3-5 MU) filled with KMeSO 4 (135), KCl (5), EGTA-Na (0.1), HEPES (10), NaCl (2), ATP (5), GTP (0.4), phosphocreatine (10) (pH of 7.2; 280-290 mOsm). Series resistance (typically 10-25 MU) was monitored throughout each experiment; recordings with a >20% change in series resistance were excluded from analysis. Focal stimulating electrodes, lower resistance patch pipettes filled with e2 Neuron 98, 992-1004.e1-e4, June 6, 2018
